A
TERN

AlphaQuest’s Terns Pharmaceuticals TERN Stock Holding History

AlphaQuest’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,008
Closed -$40.7K – 1867
2025
Q4 		$40.7K Sell
1,008
-89,875
-99% -$2.08M ﹤0.01% 1990
2025
Q3 		$683K Buy
90,883
+90,882
+9,088,200% +$580K 0.04% 606
2025
Q2 		$4 Hold
1
– – ﹤0.01% 1983
2025
Q1 		$3 Hold
1
– – ﹤0.01% 2018
2024
Q4 		$6 Sell
1
-104,534
-100% -$708K ﹤0.01% 1672
2024
Q3 		$872K Buy
+104,535
New +$860K 0.08% 412

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

AlphaQuest's TERN Position: Q1 2026 in Review

AlphaQuest sold out of Terns Pharmaceuticals (TERN) in Q1 2026, closing a stake of 1,008 shares — an estimated $40.7K sold.

AlphaQuest first reported a position in TERN in Q3 2024 and held it in 6 quarters. The position peaked at $872K in Q3 2024. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • AlphaQuest reported no remaining Terns Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 1,008 Terns Pharmaceuticals shares in Q1 2026, an estimated $40.7K.
  • AlphaQuest first reported a position in Terns Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • AlphaQuest's Terns Pharmaceuticals position peaked at $872K in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.